Drug Database
SI

sildenafil citrate (SPO1101D / Vultis / SPO1101)

✓ Approved

Seoul Pharmaceuticals · PDE5A · 小分子

什么是 sildenafil citrate?

sildenafil citrate 是一种小分子,由Seoul Pharmaceuticals研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名SPO1101D, Vultis, SPO1101
公司Seoul Pharmaceuticals
药物类别小分子
分子靶点PDE5A
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

sildenafil citrate 作用于 1 个分子靶点:

PDE5Aphosphodiesterase 5A (PDE5, CGB-PDE)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

sildenafil citrate 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Reproductive system and breast disordersErectile dysfunction✓ Approved

相关研究文献

PubMedDrug and chemical toxicology2026-11-17

Integrative computational and in-vitro evidence implicates BCL2-associated apoptotic signaling in acetyl tributyl citrate-induced microglial toxicity.

Zou Songsong S, Li Lei L, Xiang Wenjun W, Li Yanglei Y et al.

Acetyl tributyl citrate (ATBC), a synthetic plasticizer, exhibits neurotoxic potential. Microglia sustain brain homeostasis, and their apoptosis and dysfunction are key drivers of Alzheimer's disease (AD) pathogenesis. However, the mechanism connecting ATBC exposure to microglial impairment and AD susceptibility remains unclear. Here, we applied an integrative computational and in-vitro framework to investigate BCL2-centered apoptotic signaling mediating ATBC-induced microglial toxicity. We retrieved ATBC targets from five prediction databases and AD-related genes from GeneCards and OMIM, obtaining 380 overlapping genes. Five hub genes (SRC, TNF, EGFR, BCL2, and ESR1) were screened via four centrality algorithms. Functional enrichment highlighted neurodegenerative disease pathways and microglia-related apoptotic cascades. We built 127 machine-learning models using two AD GEO cohorts (GSE122603, GSE97760). The robust Lasso + XGBoost ensemble (training AUC = 0.994) identified BCL2, SRC, ESR1, and EGFR as predictive features, with SHAP analysis pinpointing BCL2 as the top contributor. Molecular docking predicted favorable ATBC-BCL2 binding (-5.363 kcal/mol), and 100 ns molecular dynamics simulations supported stable complex formation. In BV2 microglia, ATBC dose-dependently reduced cell viability (IC50 = 59.59 μM), downregulated BCL2 expression, and activated caspase-dependent apoptosis. Collectively, our integrated evidence indicates that BCL2-associated apoptotic signaling mediates ATBC-provoked microglial toxicity, suggesting a plausible mechanistic link between ATBC exposure and AD-related signatures. This study proposes a microglia-oriented mechanistic hypothesis for AD susceptibility and offers a multi-omics paradigm for plasticizer risk assessment.

PMID 43040848
阅读全文 →
PubMedACS applied bio materials2026-11-17

Pore-Engineered Nanostructured Hydroxyapatite Films for Regulating Protein-Material Interactions.

Liu Zizhen Z, Saito Masataka M, Endo Aoi A, Tagaya Motohiro M

Transparent citrate-modified hydroxyapatite nanoparticle films with tunable pore structures were fabricated through nanoparticle assembly, P123 incorporation, and controlled calcination. The films exhibited high optical transmittance (>90%) and low haze (<1%), with characteristic pore sizes of approximately 14 and 44 nm. Protein adsorption experiments revealed higher fibrinogen adsorption on large-pore films and higher hemoglobin adsorption on small-pore films. FT-IR analysis further showed greater preservation of hemoglobin secondary structure on smaller-pore films. These findings indicate that pore architecture contributes to protein adsorption behavior and differences in protein conformation, providing insights into the design of hydroxyapatite-based biointerfaces with tailored protein-material interactions.

PMID 43041159
阅读全文 →
PubMedClinical and molecular hepatology2026-11-17

Integrated metabolomics reveals nervonic acid-associated immunometabolic.

Xu Yunfeng Y, Xu Da D, Zhou Lina L, Zhang Ze Z et al.

Hepatocellular carcinoma (HCC) exhibits profound metabolic heterogeneity, yet the functional lipid metabolites driving tumor progression and immune microenvironment remodeling remain insufficiently defined. This study aimed to construct a metabolomic atlas of HCC and identify clinically relevant metabolic vulnerabilities. Untargeted metabolomic profiling was performed in 91 paired HCC and adjacent non-tumor tissues. Integrated metabolomic, transcriptomic, clinicopathological, and immune analyses characterized metabolic heterogeneity. Nervonic acid was evaluated in HCC cells, immunocompetent and immunodeficient mouse models, and knockdown and rescue experiments targeting ATP citrate lyase (ACLY). HCC showed extensive metabolic remodeling with limited metabolite-gene concordance. Clustering identified four metabolomic subtypes. The high-risk subtype MS1 exhibited poor prognosis, pronounced very-long-chain fatty acid remodeling, and immunosuppressive features. Nervonic acid, a very-long-chain monounsaturated fatty acid, was enriched in MS1, increased in HCC tissues, and associated with unfavorable survival. It promoted HCC cell proliferation, migration, invasion, and tumor growth. In immunocompetent models, nervonic acid reduced CD8+ T-cell infiltration and increased M2-like macrophage enrichment. Exploratory CD8 depletion suggested attenuation of the nervonic acid-associated tumor growth increment. Coordinated lipid remodeling included altered free fatty acid composition, enhanced fatty acid uptake, increased cholesterol abundance, and changes in membrane lipid order. Nervonic acid induced an ACLY-centered lipogenic program; in HCC cells, ACLY knockdown attenuated malignant phenotypes and lipid accumulation, and ACLY rescue restored these responses. Nervonic acid marks an aggressive HCC subtype with distinct immune features. Knockdown and rescue in HCC cells implicate ACLY in lipid remodeling. The prognostic value of tumor nervonic acid requires independent validation.

PMID 43041060
阅读全文 →
PubMedArchives of pathology & laboratory medicine2026-11-17

Correction of Platelet Count Bias in EDTA-PTCP by Reconstructing the Spatial Distribution of Platelets.

Yang Meng M, Xing Yuan Y, Luo Huixian H, Ouyang Jiayi J et al.

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia (EDTA-PTCP) is a common pre-analytical confounder that causes spuriously low platelet (PLT) counts and may lead to misdiagnosis or inappropriate clinical management. Currently employed correction methods have limited effectiveness and practicality. To develop and validate PLT-pro2.0, a whole-slide imaging (WSI)-based method for correcting PLT counts in EDTA-PTCP without requiring an additional blood sample. Blood samples collected between August 2023 and December 2024 from 93 patients diagnosed with EDTA-PTCP were included. Blood slides underwent WSI and were analyzed using an optimized You Only Look Once-based platelet detection model (YOLO-PLT) to automate the recognition and counting of individual PLTs and clumps. By simulating spatial distribution patterns, PLT-pro2.0 reconstructs the original linear distribution on the slide and calculates the PLT:RBC ratio at the body-tail junction. A manual PLT count performed on each paired sodium citrate sample served as the reference standard. Amikacin deaggregation at 10, 30, 60, and 120 minutes was evaluated in parallel. YOLO-PLT distinguished independent PLTs and aggregates. Non-aggregated samples showed a linear gradient (Pearson r = 0.863), whereas EDTA-PTCP samples displayed nonlinear tail aggregation. PLT-pro2.0 correlated strongly with reference values (Spearman r = 0.906; 95% CI, 0.861-0.937) with an average relative deviation of -0.9%. Passing-Bablok analysis indicated no proportional bias (slope 95% CI, 0.9496-1.1921) and slight constant bias (intercept 95% CI, -33.1884 to -0.8571). Amikacin showed poorer agreement. PLT-pro2.0 provides a rapid, objective, and accurate WSI-based correction strategy for EDTA-PTCP, particularly for samples difficult to correct using conventional methods.

PMID 43042963
阅读全文 →
PubMedMolecular medicine (Cambridge, Mass.)2026-11-17

Glycine N-methyltransferase modulates mitochondria-derived formate utilization and central carbon metabolism during methotrexate therapy.

Sou Nga-Lai NL, Chen Yi-Ming YM, Chen Der-Yuan DY, Nee Yeu-Jye YJ et al.

Mutations or reduced expression in glycine N-methyltransferase (GNMT) has been linked to liver diseases. Methotrexate (MTX) is commonly prescribed for the treatment of human rheumatic diseases. We previously demonstrated that MTX selectively inhibits the partitioning of mitochondria derived formate pathways, including glycine cleavage system (GCS). We also demonstrated that GNMT expression is essential for methyl group supply, intracellular folate homeostasis and MTX toxicity. We tested the hypothesis that GNMT regulates the metabolic response to low-dose methotrexate by altering mitochondrial one-carbon metabolism, thereby influencing glycine-derived one-carbon partitioning, DNA methylation, and central carbon metabolism. Metabolic alterations of mitochondrial one carbon metabolism and TCA cycle were investigated in liver derived cell-lines with/without human GNMT expression, as well as in wild-type (WT, Gnmt+/+) and GNMT knockout (KO, Gnmt-/-) mouse models treated with MTX using stable isotopic tracers and GC/MS. MTX inhibited deoxythymidylate (dTMP) synthesis from mitochondria derived formate in both WT and Gnmt-/- mice bone marrow. Deletion of Gnmt in mice decreased enrichment in 5-methyl-2'-deoxycytidine (5-mdC) but not dTMP synthesis from GCS using [2-13 C] glycine tracer. Interestingly, MTX inhibited 5-mdC enrichments in Gnmt+/+ but promoted that in Gnmt-/- in the bone marrow, indicating gene-drug interactions in GCS activity. MTX decreased liver pyruvate concentrations in both Gnmt+/+ and Gnmt-/-, whereas MTX increased plasma citrate concentration in Gnmt+/+ but not in Gnmt-/-. MTX suppressed liver alpha-ketoglutarate but increased malate concentrations in Gnmt+/+ but not Gnmt-/-. The present study provides evidence on the interactions between MTX and GNMT function and provides new insights on how this essential gene may affect mitochondria derived formate dependent pathways and central carbon metabolism during MTX therapy. In patients taking long-term MTX therapy, genetic factors such as hepatic GNMT function should be taken into consideration.

PMID 43040217
阅读全文 →
PubMedJournal of molecular neuroscience : MN2026-11-16

Integrated Network Toxicology, Machine Learning, and Structural Biology Identify a Candidate Gene Network Linking Predicted Acetyl Tributyl Citrate Targets to Alzheimer's Disease.

Wang Yue Y, Zhang Ying Y, Wei Honghui H, Li Yang Y et al.

As a common plasticizer, acetyl tributyl citrate (ATBC) poses a potential public health risk, yet its role in Alzheimer's disease (AD) is unclear. This study seeks to identify candidate molecular links between computationally predicted ATBC targets and AD-associated transcriptional alterations. We combined differential gene expression and co-expression results from two AD-related transcriptomic datasets with in silico ATBC target predictions from ChEMBL, PharmMapper, and SwissTargetPrediction, followed by machine learning feature selection, network toxicology, and molecular docking. We identified sixty-nine overlapping candidate genes shared among AD differentially expressed genes, AD-associated WGCNA modules, and computationally predicted ATBC targets. Among these, three genes-Interferon-stimulated gene 20 kDa (ISG20), Cytochrome P450 26A1 (CYP26A1), and β-1,3-Galactosyltransferase-1 (B3GALT1)-were further prioritized through machine learning. Docking scores were - 5.1 kcal/mol for ISG20, - 5.4 kcal/mol for CYP26A1, and - 4.6 kcal/mol for B3GALT1. These computational results suggest plausible binding poses. Our integrated analysis nominates ISG20, B3GALT1, and CYP26A1 as candidate molecular links between predicted ATBC targets and AD-associated transcriptional changes, providing a computational foundation for experimental validation.

PMID 43037874
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多sildenafil citrate